CD274 and neoplasm: Many clinical studies have demonstrated that the expression of PD-L1 on tumour cells or in the tumour microenvironment is associated with poor clinical prognosis and can predict the progression of several types of tumours [7], [8], [9], and this molecule has become the most widely adopted indicator of tumour progression [10].